SB2329: Emerging Pathogen Preparedness Program Authorization Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.
Plain-language summary
This bill creates a new program at the FDA (Food and Drug Administration) to prepare for future disease outbreaks by improving how the government oversees medical treatments and preventive measures. The program would help speed up and improve the regulatory process for developing medicines and vaccines during pandemics. Medical countermeasures are drugs, vaccines, or other medical tools used to prevent or treat serious diseases. The bill is currently in the early stage after being introduced in Congress, with sponsors from both parties.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB2329: Emerging Pathogen Preparedness Program Authorization Act